Objective To evaluate the prognostic strengths of American Joint Committee on Cancer
(AJCC) staging and American Thyroid Association (ATA) risk classification in well …

Background: The eighth edition of the American Joint Committee on Cancer (AJCC) staging
system has reclassified up to one third of differentiated thyroid cancer patients into one of the …

Background: The 2015 American Thyroid Association (ATA) Risk Stratification System for
differentiated thyroid cancer (DTC) is designed to predict recurring/persisting disease but not …

Background Differentiated thyroid carcinoma (DTC) patients have a long survival period and
good prognosis, so they are easily affected by competing risk events. The purpose of this …

Background Several staging systems have been developed to predict the risk of mortality in
patients with differentiated thyroid cancer (DTC). However, none of them have been shown …

Background Recent revision significantly changed the American Joint Committee on Cancer
(AJCC) staging criteria for differentiated thyroid cancer (DTC). To quantitatively evaluate …

Objective Poorly differentiated thyroid cancer (PDTC) is a rare, but aggressive thyroid cancer
(TC) and a main cause of death from non‐anaplastic follicular cell‐derived TC. Assessing …

Abstract Background In 2018, the American Joint Committee on Cancer (AJCC) 8 th edition
(AJCC8) was introduced to replace the previous version (AJCC7) due to superiority of …

Background: One of the most widely used risk stratification systems for estimating individual
patients' risk of persistent or recurrent differentiated thyroid cancer (DTC) is the American …

Background: The American Joint Committee on Cancer Cancer Staging System for
differentiated thyroid cancer has been recently revised. The purpose of this study was to …